"Vi er et ideelt lokalsykehus i Oslo for innbyggerne i vestlige bydeler. Ambisjonen er å være et foretrukket lokalsykehus. Vi har driftsavtale med Helse Sør-Øst innen medisin, kirurgi, revmatologi og psykisk helsevern og tverrfaglig spesialisert rusbehandling. Vi har vi region- og landsfunksjoner på flere områder og har et stort forsknings- og innovasjonsmiljø. Sykehuset har ca 1700 ansatte og ligger i nærheten av Majorstuen med alt av kollektiv- og servicetilbud."

During the past decade, Department of Rheumatology, Diakonhjemmet Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Rheumatology, Diakonhjemmet Hospital" #1 collaborator was "South-Eastern Norway Regional Health Authority" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Martina Hansen's Hospital" with 1 trials as a collaborator, "Oslo University Hospital" with 1 trials as a collaborator and "The Research Council of Norway" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Department of Rheumatology, Diakonhjemmet Hospital" are "Rheumatoid Arthritis" (3 trials), "Psoriatic Arthritis" (2 trials), "Spondyloarthritis" (2 trials), "Carpal Tunnel Syndrome" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Department of Rheumatology, Diakonhjemmet Hospital" in a lesser frequency.

Most popular intervention types in "Department of Rheumatology, Diakonhjemmet Hospital" are "Drug" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anti-TNF alpha therapy" (1 trials), "Biosimilar infliximab" (1 trials), "Co-medication: Synthetic DMARDs" (1 trials), "Conventional treat-to-target" (1 trials) and "Imaging informed treat-to-target" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Rheumatology, Diakonhjemmet Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Rheumatology, Diakonhjemmet Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Rheumatology, Diakonhjemmet Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Rheumatology, Diakonhjemmet Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".